Revenue grew 6.4% year-over-year to $2.56 billion in Q2 2026, driven by price increases and acquisitions, while net income rose to $296.4 million. Operating income declined due to higher impairments and costs, but adjusted EBITDA improved. Litigation and regulatory risks remain significant.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.